BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
19.06
-0.31 (-1.60%)
Dec 29, 2025, 4:00 PM EST - Market closed
BrainsWay Market Cap
BrainsWay has a market cap or net worth of $384.99 million as of December 29, 2025. Its market cap has increased by 95.87% in one year.
Market Cap
384.99M
Enterprise Value
318.98M
1-Year Change
95.87%
Ranking
Category
Stock Price
$19.06
Market Cap Chart
Since September 3, 2013, BrainsWay's market cap has increased from $178.92M to $384.99M, an increase of 115.17%. That is a compound annual growth rate of 6.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 28, 2025 | 384.99M | 113.44% |
| Dec 31, 2024 | 180.37M | 70.88% |
| Dec 31, 2023 | 105.55M | 216.46% |
| Dec 29, 2022 | 33.35M | -73.96% |
| Dec 30, 2021 | 128.06M | 62.02% |
| Dec 31, 2020 | 79.04M | -26.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 970.24B |
| Johnson & Johnson | 501.78B |
| AbbVie | 407.61B |
| UnitedHealth Group | 298.32B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.08B |
| Novo Nordisk | 232.28B |